BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Adaptimmune Ltd. 

57c Milton Park

Abingdon  Oxfordshire  OX14 4RX  United Kingdom
Phone: +44-(0)-1235-438-642 Fax: +44-(0)-1235-438-607


SEARCH JOBS










 Company News
Adaptimmune Announces New Additions To Senior Clinical Management 5/20/2015 2:10:37 PM
Citi Appointed Depositary Bank For Adaptimmune’s ADR Programme 5/19/2015 1:11:40 PM
Adaptimmune Announces Upcoming Data Presentation At The 2015 Annual American Society Of Gene And Cell Therapy (ASGCT) Meeting 5/13/2015 12:52:00 PM
Adaptimmune Announces Appointment Of Vice President Of Investor Relations 5/13/2015 7:34:23 AM
Adaptimmune Announces Closing Of IPO 5/11/2015 10:24:13 AM
Adaptimmune Announces Pricing Of IPO 5/6/2015 10:59:12 AM
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/10/2015 6:06:18 AM
Adaptimmune Ltd. Appoints Lawrence M. Alleva To Its Board Of Directors 3/10/2015 3:00:59 PM
Adaptimmune Ltd. Strengthens Management Team With Key Executive Hires 3/4/2015 10:33:00 AM
Adaptimmune Ltd. Announces Interim Results From Pilot Trial Of Its Engineered NY-ESO T Cells Targeting Synovial Sarcoma 10/17/2014 9:37:09 AM
123